Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Reactogenicity and Immunogenicity of an H5N1 VLP
This study has been completed.
Study NCT00519389   Information provided by Novavax

First Received on August 20, 2007.   Last Updated on March 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pandemic Influenza
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
H5/N1 VLP Vaccine
Placebo
Sponsors listed in this trial
Novavax


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services